prednisone has been researched along with Myeloproliferative Disorders in 29 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 7.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "A case of myelodysplasia (refractory anaemia with excessive blasts) arising 7 years after a 3 year period of intermittent monthly treatment cycles with melphalan for multiple myelomas is reported." | 7.66 | [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case]. ( Boccafogli, A; Scolozzi, R, 1983) |
| "Data were obtained from a Phase II, randomized, double-blind Bayesian pick-the-winner trial of prednisone and pomalidomide in patients with MPN-associated myelofibrosis and anemia (red blood cell-transfusion dependence)." | 5.19 | Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia. ( Cervantes, F; Gale, RP; Hudgens, S; Khan, ZM; Mesa, R; Passamonti, F; Rivera, C; Tefferi, A; Tencer, T; Verstovsek, S, 2014) |
| "In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myeloma (MM) were randomised between cyclophosphamide (600 mg m-2) and epirubicin (70 mg m-2), administered every 3 weeks for three courses and both associated with prednisone and interferon-alpha2b." | 5.08 | Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma. ( Ascari, E; Barbarano, L; Bergonzi, C; Brugnatelli, S; De Paoli, A; Di Stasi, M; Mora, O; Petrini, M; Piccinini, L; Piva, N; Riccardi, A; Rinaldi, E; Trotti, G; Ucci, G, 1996) |
| "To report a patient with lung cancer and idiopathic myelofibrosis with myeloid metaplasia who developed purpura and acute renal failure while receiving levofloxacin, and review the existing literature on quinolone nephrotoxicity." | 3.71 | Nephrotoxicity and purpura associated with levofloxacin. ( De Simone, C; Famularo, G, 2002) |
| "Twenty-two patients who had metastatic breast cancer previously treated with combination chemotherapy, cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) or CMF with vincristine and prednisone, were treated with Carminomycin (carubicin) 20 mg/m2 body surface area by intravenous bolus injection once every 3 weeks." | 3.67 | Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer. ( Aboud, A; Blumenschein, GR; Bodey, GP; Esparza, L; Hortobagyi, G; Issell, B; Yap, HY, 1984) |
| "A case of myelodysplasia (refractory anaemia with excessive blasts) arising 7 years after a 3 year period of intermittent monthly treatment cycles with melphalan for multiple myelomas is reported." | 3.66 | [Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case]. ( Boccafogli, A; Scolozzi, R, 1983) |
| " Particularly in patients aged over 80 years, to avoid side effects it is essential to adjust dosage and route of administration of chemotherapy." | 2.42 | [Malignant lymphoma, multiple myeloma and myeloproliferative diseases in the elderly]. ( Umeda, M, 2004) |
| " This study aimed to evaluate the response and the adverse events of treatment with imatinib mesylate (IM) compared to conventional therapy using vinblastine and prednisolone (VP) in canine cutaneous MCTs." | 1.72 | Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone. ( Alexandre, PA; Brandão, PE; Casagrande, TAC; Dagli, MLZ; de Queiroz, GF; Fukumasu, H; Macedo, TR; Matera, JM; Melo, SR; Pinto, ACBCF, 2022) |
| "In our patient the occurrence of a plasmocytoma with a dramatic course leads to suspect an underlying complex genetic aberration." | 1.27 | Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature. ( Bosman, C; Calvieri, S; Carfagna, GF; De Rosa, F; Franchi, F; Seminara, P, 1984) |
| "Busulfan has been the drug most widely used during pregnancy, and it appears not to cause fetal malformations when used alone." | 1.26 | Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years. ( Miller, JB, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (65.52) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 4 (13.79) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Macedo, TR | 1 |
| de Queiroz, GF | 1 |
| Casagrande, TAC | 1 |
| Alexandre, PA | 1 |
| Brandão, PE | 1 |
| Fukumasu, H | 1 |
| Melo, SR | 1 |
| Dagli, MLZ | 1 |
| Pinto, ACBCF | 1 |
| Matera, JM | 1 |
| Qu, S | 1 |
| Xu, Z | 1 |
| Qin, T | 1 |
| Li, B | 1 |
| Pan, L | 1 |
| Chen, J | 1 |
| Yan, X | 1 |
| Wu, J | 1 |
| Zhang, Y | 2 |
| Zhang, P | 1 |
| Gale, RP | 2 |
| Xiao, Z | 1 |
| Pousa-Martínez, M | 1 |
| Sánchez-Aguilar, D | 1 |
| Aliste, C | 1 |
| Vázquez-Veiga, H | 1 |
| Tefferi, A | 1 |
| Hudgens, S | 1 |
| Mesa, R | 1 |
| Verstovsek, S | 1 |
| Passamonti, F | 1 |
| Cervantes, F | 1 |
| Rivera, C | 1 |
| Tencer, T | 1 |
| Khan, ZM | 1 |
| Chen, X | 1 |
| Li, Y | 1 |
| Lei, P | 1 |
| Zhai, Y | 1 |
| Liu, L | 1 |
| Moritake, H | 1 |
| Yamada, A | 1 |
| Kimoto, Y | 1 |
| Sawa, D | 1 |
| Shimonodan, H | 1 |
| Nunoi, H | 1 |
| Famularo, G | 1 |
| De Simone, C | 1 |
| RIECHE, K | 1 |
| Umeda, M | 1 |
| Franchi, F | 1 |
| De Rosa, F | 1 |
| Seminara, P | 1 |
| Calvieri, S | 1 |
| Carfagna, GF | 1 |
| Bosman, C | 1 |
| Yates, RW | 1 |
| Weller, RE | 1 |
| Feldman, BF | 1 |
| Aboud, A | 1 |
| Yap, HY | 1 |
| Esparza, L | 1 |
| Blumenschein, GR | 1 |
| Hortobagyi, G | 1 |
| Issell, B | 1 |
| Bodey, GP | 1 |
| Soffer, T | 1 |
| Chan, WC | 1 |
| Brynes, RK | 1 |
| Vogler, WR | 1 |
| O'Neal, S | 1 |
| Sølling, K | 1 |
| Nielsen, JL | 1 |
| Sølling, J | 1 |
| Ellegaard, J | 1 |
| Scolozzi, R | 1 |
| Boccafogli, A | 1 |
| Sacher, RA | 1 |
| McGinniss, MM | 1 |
| Shashaty, GG | 1 |
| Jacobson, RJ | 1 |
| Rath, CE | 1 |
| Brugnatelli, S | 1 |
| Riccardi, A | 1 |
| Ucci, G | 1 |
| Mora, O | 1 |
| Barbarano, L | 1 |
| Piva, N | 1 |
| Piccinini, L | 1 |
| Bergonzi, C | 1 |
| De Paoli, A | 1 |
| Di Stasi, M | 1 |
| Rinaldi, E | 1 |
| Trotti, G | 1 |
| Petrini, M | 1 |
| Ascari, E | 1 |
| Lange, B | 1 |
| Madewell, BR | 1 |
| Crow, SE | 1 |
| Nickerson, TR | 1 |
| Wands, JR | 1 |
| Chura, CM | 1 |
| Roll, FJ | 1 |
| Maddrey, WC | 1 |
| Kohn, G | 1 |
| Manny, N | 1 |
| Eldor, A | 1 |
| Cohen, MM | 1 |
| Miller, JB | 1 |
| Ben-Izhak, C | 1 |
| Shechter, Y | 1 |
| Tatarsky, I | 1 |
| Maréchaud, R | 1 |
| Neau, JP | 1 |
| Quéron, B | 1 |
| Lessard, M | 1 |
| Babin, P | 1 |
| Lefevre, JP | 1 |
| Sudre, Y | 1 |
| Ajlouni, K | 1 |
| Millman, WL | 1 |
| Libnoch, JA | 1 |
| Theil, GB | 1 |
| Grundmann, E | 1 |
| Fritzsche, R | 1 |
| Teasdale, JM | 1 |
| Worth, AJ | 1 |
| Corey, MJ | 1 |
| Vanista, J | 1 |
| Srámková, L | 1 |
| Krakoff, IH | 1 |
| Balis, ME | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial[NCT03003325] | Phase 2 | 127 participants (Actual) | Interventional | 2017-02-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for prednisone and Myeloproliferative Disorders
| Article | Year |
|---|---|
Usefulness of ultrasound in the diagnosis and follow-up of pyoderma gangrenosum.
Topics: Aged; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Myeloproliferative Disorders; Pre | 2017 |
Usefulness of ultrasound in the diagnosis and follow-up of pyoderma gangrenosum.
Topics: Aged; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Myeloproliferative Disorders; Pre | 2017 |
[Malignant lymphoma, multiple myeloma and myeloproliferative diseases in the elderly].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2004 |
[Malignant lymphoma, multiple myeloma and myeloproliferative diseases in the elderly].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2004 |
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother | 2000 |
The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
Topics: Acute Disease; Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemother | 2000 |
2 trials available for prednisone and Myeloproliferative Disorders
| Article | Year |
|---|---|
Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.
Topics: Anemia; Bayes Theorem; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Myeloproliferativ | 2014 |
Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.
Topics: Anemia; Bayes Theorem; Double-Blind Method; Female; Glucocorticoids; Humans; Male; Myeloproliferativ | 2014 |
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cycl | 1996 |
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cycl | 1996 |
24 other studies available for prednisone and Myeloproliferative Disorders
| Article | Year |
|---|---|
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.
Topics: Animals; Dog Diseases; Dogs; Imatinib Mesylate; Myeloproliferative Disorders; Prednisone; Vinblastin | 2022 |
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone.
Topics: Animals; Dog Diseases; Dogs; Imatinib Mesylate; Myeloproliferative Disorders; Prednisone; Vinblastin | 2022 |
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Predni | 2022 |
Ruxolitinib combined with prednisone, thalidomide and danazol in patients with myelofibrosis: Results of a pilot study.
Topics: Anemia; Danazol; Hemoglobins; Humans; Myeloproliferative Disorders; Nitriles; Pilot Projects; Predni | 2022 |
Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 13; Chromosomes, Hum | 2010 |
Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 13; Chromosomes, Hum | 2010 |
Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.
Topics: Antimetabolites, Antineoplastic; Biomarkers; Biomarkers, Tumor; Cytarabine; Cytokines; Disease Progr | 2012 |
Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.
Topics: Antimetabolites, Antineoplastic; Biomarkers; Biomarkers, Tumor; Cytarabine; Cytokines; Disease Progr | 2012 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruption | 2002 |
Nephrotoxicity and purpura associated with levofloxacin.
Topics: Acute Kidney Injury; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Diuretics; Drug Eruption | 2002 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neo | 1964 |
[DATA TO THE DIAGNOSTIC VALUE OF FIBRINOGEN DETERMINATION IN MALIGNANT DISEASES].
Topics: Cyclophosphamide; Fibrinogen; Hodgkin Disease; Humans; Metaplasia; Myeloproliferative Disorders; Neo | 1964 |
Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature.
Topics: Eosinophilia; Eosinophils; Humans; Hydroxyurea; Immunoglobulin lambda-Chains; Immunoglobulin Light C | 1984 |
Hypereosinophilic syndrome and plasmocytoma. Report of a case and review of the literature.
Topics: Eosinophilia; Eosinophils; Humans; Hydroxyurea; Immunoglobulin lambda-Chains; Immunoglobulin Light C | 1984 |
Myeloproliferative disease in a cat.
Topics: Animals; Blood Cell Count; Blood Transfusion; Bone Marrow; Cat Diseases; Cats; Cyclophosphamide; Dox | 1984 |
Myeloproliferative disease in a cat.
Topics: Animals; Blood Cell Count; Blood Transfusion; Bone Marrow; Cat Diseases; Cats; Cyclophosphamide; Dox | 1984 |
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carubicin; Cyclophosp | 1984 |
Carminomycin. A new anthracycline analog in the treatment of advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carubicin; Cyclophosp | 1984 |
Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Eos | 1984 |
Myeloproliferative disorder with profound hypereosinophilia associated with chemotherapy for breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Eos | 1984 |
Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma.
Topics: Adolescent; Adult; Aged; Child; Chlorambucil; Humans; Immunoglobulin kappa-Chains; Immunoglobulin la | 1982 |
Free light chains of immunoglobulins in serum from patients with leukaemias and multiple myeloma.
Topics: Adolescent; Adult; Aged; Child; Chlorambucil; Humans; Immunoglobulin kappa-Chains; Immunoglobulin la | 1982 |
[Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
Topics: Blood Transfusion; Erythrocyte Transfusion; Female; Humans; Melphalan; Middle Aged; Multiple Myeloma | 1983 |
[Dysmyelopoietic syndrome 7 years after melphalan treatment of multiple myeloma. Clinical case].
Topics: Blood Transfusion; Erythrocyte Transfusion; Female; Humans; Melphalan; Middle Aged; Multiple Myeloma | 1983 |
The occurrence of an auto-immune hemolytic anemia with anti-U specificity in a patient with myelodysplastic syndrome.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Blood Grouping and Crossmatching; Blood T | 1982 |
The occurrence of an auto-immune hemolytic anemia with anti-U specificity in a patient with myelodysplastic syndrome.
Topics: Aged; Anemia, Hemolytic, Autoimmune; Antibody Specificity; Blood Grouping and Crossmatching; Blood T | 1982 |
Infectious peritonitis in a cat that subsequently developed a myeloproliferative disorder.
Topics: Ampicillin; Animals; Cat Diseases; Cats; Male; Melphalan; Myeloproliferative Disorders; Peritonitis; | 1978 |
Infectious peritonitis in a cat that subsequently developed a myeloproliferative disorder.
Topics: Ampicillin; Animals; Cat Diseases; Cats; Male; Melphalan; Myeloproliferative Disorders; Peritonitis; | 1978 |
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
Topics: Adolescent; Adult; Antibodies, Viral; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubi | 1975 |
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.
Topics: Adolescent; Adult; Antibodies, Viral; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Daunorubi | 1975 |
De novo appearance of the ph-1 chromosome in a previously monosomic bone marrow (45,XX,-6): conversion of a myeloproliferative disorder to acute myelogenous leukemia.
Topics: Adult; Alkaline Phosphatase; Blood Transfusion; Bone Marrow Cells; Bone Marrow Examination; Chromoso | 1975 |
De novo appearance of the ph-1 chromosome in a previously monosomic bone marrow (45,XX,-6): conversion of a myeloproliferative disorder to acute myelogenous leukemia.
Topics: Adult; Alkaline Phosphatase; Blood Transfusion; Bone Marrow Cells; Bone Marrow Examination; Chromoso | 1975 |
Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years.
Topics: Aged; Busulfan; Child; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Diso | 1976 |
Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years.
Topics: Aged; Busulfan; Child; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Myeloproliferative Diso | 1976 |
Significance of multiple types of antibodies on red blood cells of patients with positive direct antiglobulin test: a study of monospecific antiglobulin reactions in 85 patients.
Topics: Antibodies, Anti-Idiotypic; Antibody Specificity; Blood Group Antigens; Coombs Test; Humans; Leukemi | 1985 |
Significance of multiple types of antibodies on red blood cells of patients with positive direct antiglobulin test: a study of monospecific antiglobulin reactions in 85 patients.
Topics: Antibodies, Anti-Idiotypic; Antibody Specificity; Blood Group Antigens; Coombs Test; Humans; Leukemi | 1985 |
[Hypereosinophilic syndrome: a new case of myeloproliferative type].
Topics: Blood Cell Count; Eosinophilia; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Myeloprol | 1985 |
[Hypereosinophilic syndrome: a new case of myeloproliferative type].
Topics: Blood Cell Count; Eosinophilia; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Myeloprol | 1985 |
Letter: Hyperphosphatemia and hypocalcemia in myeloproliferative disorder.
Topics: Adult; Cytarabine; Humans; Hypercalcemia; Hypocalcemia; Male; Myeloproliferative Disorders; Phosphat | 1974 |
Letter: Hyperphosphatemia and hypocalcemia in myeloproliferative disorder.
Topics: Adult; Cytarabine; Humans; Hypercalcemia; Hypocalcemia; Male; Myeloproliferative Disorders; Phosphat | 1974 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D | 1974 |
A missing group C chromosome in the bone marrow cells of three children with myeloproliferative disease.
Topics: Adolescent; Aneuploidy; Autopsy; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Bone Marrow Exami | 1970 |
A missing group C chromosome in the bone marrow cells of three children with myeloproliferative disease.
Topics: Adolescent; Aneuploidy; Autopsy; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Bone Marrow Exami | 1970 |
[Panmyelopathy following acute hepatitis].
Topics: Acute Disease; Adult; Blood Transfusion; Bone Diseases; Bone Marrow Diseases; Bone Marrow Examinatio | 1968 |
[Panmyelopathy following acute hepatitis].
Topics: Acute Disease; Adult; Blood Transfusion; Bone Diseases; Bone Marrow Diseases; Bone Marrow Examinatio | 1968 |
Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy.
Topics: Adult; Allopurinol; Carbon Isotopes; Child; Cyclophosphamide; Enzyme Therapy; Female; Humans; Hydroc | 1966 |
Allopurinol in the prevention of hyperuricaemia secondary to the treatment of neoplastic diseases with alkylating agents, adrenal steroids, and radiation therapy.
Topics: Adult; Allopurinol; Carbon Isotopes; Child; Cyclophosphamide; Enzyme Therapy; Female; Humans; Hydroc | 1966 |